Kevin Fone

Professor Fone is a Professor of Neuroscience at the University of Nottingham. His research interests include improving the understanding of the neurobiological aetiology of common CNS disorders, such as schizophrenia, depression, PTSD and ADHD, and helping develop novel therapeutic treatment strategies for these. His research uses integrated physiology to investigate the functional role of 5-HT and dopamine in the CNS and to evaluate the impact of early-life interventions on brain development and behaviour. The fundamental approach is to concomitantly measure neurotransmitter function, neurochemistry and behaviour in paradigms designed to model CNS disorders. Kevin has benefited from extensive funding from Research Councils, EU consortiums, and many pharmaceutical companies from all over the world. He is a Fellow of the British Pharmacological Society, a member of the scientific advisory board for the ECNP and has been President for both the International Society for Serotonin Research and the British Association for Psychopharmacology.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Awakn Life Sciences

Awakn Life Sciences is a biotechnology company focused on research, development, and delivery of psychedelic medicines for the treatment of mental health conditions.


Industries

Headquarters

Toronto, Canada

Employees

11-50

Links